THERE is a shortage of certain medicines in the market which has been noted lately. This is not a new phenomenon and has been seen ever since countries around the world started emerging from lockdown measures and resumed economic activities.
Coupled with an unprecedented amount of demand for common medications brought on by the high incidence rate of the Omicron Covid-19 variant, many pharmaceuticals, both manufacturers and distributors alike, were caught off guard.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
